Improving the tools of clinical pharmacology: Goals for 2017 and beyond

Current trends in pronounced late-stage attrition rates of promising drug candidates are a pressing concern for patients, providers, and other stakeholders across the health care system. Here, we describe six areas in which clinical pharmacology methods and frameworks can help ameliorate these trend...

Full description

Saved in:
Bibliographic Details
Published inClinical pharmacology and therapeutics Vol. 101; no. 1; p. 22
Main Authors Zineh, I, Abernethy, D, Hop, Ceca, Bello, A, McClellan, M B, Daniel, G W, Romine, M H
Format Journal Article
LanguageEnglish
Published United States 01.01.2017
Subjects
Delivery of Health Care - trends
Drug Approval
Drug Design
Goals
Humans
Pharmacology, Clinical - trends
Time Factors
Online AccessGet more information

Cover

More Information
Summary:Current trends in pronounced late-stage attrition rates of promising drug candidates are a pressing concern for patients, providers, and other stakeholders across the health care system. Here, we describe six areas in which clinical pharmacology methods and frameworks can help ameliorate these trends in late-stage attrition and increase the efficiency of drug development and evaluation. These recommendations are based, in part, on previous stakeholder engagement and input, as well as a previously published white paper.
ISSN:1532-6535
DOI:10.1002/cpt.530